Cytomegalovirus Vaccine Strain Towne-Derived Dense Bodies Induce Broad Cellular Immune Responses and Neutralizing Antibodies That Prevent Infection of Fibroblasts and Epithelial Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytomegalovirus Vaccine Strain Towne-Derived Dense Bodies Induce Broad Cellular Immune Responses and Neutralizing Antibodies That Prevent Infection of Fibroblasts and Epithelial Cells
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 87, Issue 20, Pages 11107-11120
Publisher
American Society for Microbiology
Online
2013-08-08
DOI
10.1128/jvi.01554-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preliminary Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women with Primary Cytomegalovirus Infection
- (2012) Ennio Polilli et al. Clinical and Vaccine Immunology
- Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin
- (2012) A. E. Fouts et al. JOURNAL OF VIROLOGY
- Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus
- (2012) Tong-Ming Fu et al. VACCINE
- Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies
- (2012) Rebecca J. Loomis et al. VACCINE
- Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
- (2012) Barbara Kropff et al. PLoS Pathogens
- Functional Interaction of Nuclear Domain 10 and Its Components with Cytomegalovirus after Infections: Cross-Species Host Cells versus Native Cells
- (2011) Ruth Cruz Cosme et al. PLoS One
- B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
- (2011) Sonja Pötzsch et al. PLoS Pathogens
- Antibody Treatment Promotes Compensation for Human Cytomegalovirus-Induced Pathogenesis and a Hypoxia-Like Condition in Placentas with Congenital Infection
- (2010) Ekaterina Maidji et al. AMERICAN JOURNAL OF PATHOLOGY
- Update on the current status of cytomegalovirus vaccines
- (2010) Heungsup Sung et al. Expert Review of Vaccines
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates
- (2010) Vasco Filipe et al. PHARMACEUTICAL RESEARCH
- Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications
- (2010) M. Grazia Revello et al. REVIEWS IN MEDICAL VIROLOGY
- Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant
- (2009) Robert F. Pass JOURNAL OF CLINICAL VIROLOGY
- Findings and conclusions from CMV hyperimmune globulin treatment trials
- (2009) Stuart P. Adler et al. JOURNAL OF CLINICAL VIROLOGY
- Cytomegalovirus Reinfections in Healthy Seroimmune Women
- (2009) Shannon A. Ross et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccine Prevention of Maternal Cytomegalovirus Infection
- (2009) Robert F. Pass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection
- (2008) G. Gerna et al. JOURNAL OF GENERAL VIROLOGY
- Human Cytomegalovirus–Specific Memory CD8+and CD4+T Cell Differentiation after Primary Infection
- (2008) Daniele Lilleri et al. JOURNAL OF INFECTIOUS DISEASES
- Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection
- (2008) Xiaohong Cui et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now